| How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and … WJ Paulus, C Tschöpe, JE Sanderson, C Rusconi, FA Flachskampf, ... European heart journal 28 (20), 2539-2550, 2007 | 3881 | 2007 |
| Diastolic stiffness of the failing diabetic heart L van Heerebeek, N Hamdani, ML Handoko, I Falcao-Pires, RJ Musters, ... Circulation 117 (1), 43-51, 2008 | 879 | 2008 |
| Myocardial structure and function differ in systolic and diastolic heart failure L van Heerebeek, A Borbély, HWM Niessen, JGF Bronzwaer, ... Circulation 113 (16), 1966-1973, 2006 | 847 | 2006 |
| Cardiomyocyte stiffness in diastolic heart failure A Borbély, J van der Velden, Z Papp, JGF Bronzwaer, I Edes, ... Circulation 111 (6), 774-781, 2005 | 685 | 2005 |
| Hypophosphorylation of the stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium A Borbély, I Falcao-Pires, L van Heerebeek, N Hamdani, I Édes, C Gavina, ... Circulation research 104 (6), 780-786, 2009 | 436 | 2009 |
| Diabetes Mellitus Worsens Diastolic Left Ventricular Dysfunction in Aortic Stenosis Through Altered Myocardial Structure and Cardiomyocyte StiffnessClinical Perspective I Falcão-Pires, N Hamdani, A Borbély, C Gavina, CG Schalkwijk, ... Circulation 124 (10), 1151-1159, 2011 | 254 | 2011 |
| Circulating ACE2 activity correlates with cardiovascular disease development K Úri, M Fagyas, A Kertész, A Borbély, C Jenei, O Bene, Z Csanádi, ... Journal of the Renin-Angiotensin-Aldosterone System 17 (4), 1470320316668435, 2016 | 107 | 2016 |
| Peroxynitrite-induced α-actinin nitration and contractile alterations in isolated human myocardial cells A Borbély, A Tóth, I Édes, L Virág, JG Papp, A Varró, WJ Paulus, ... Cardiovascular research 67 (2), 225-233, 2005 | 105 | 2005 |
| Functional effects of protein kinase C-mediated myofilament phosphorylation in human myocardium J Van Der Velden, NA Narolska, RR Lamberts, NM Boontje, A Borbély, ... Cardiovascular research 69 (4), 876-887, 2006 | 94 | 2006 |
| Myofilament dysfunction in cardiac disease from mice to men N Hamdani, M de Waard, AE Messer, NM Boontje, V Kooij, S van Dijk, ... Journal of muscle research and cell motility 29 (6), 189-201, 2008 | 81 | 2008 |
| Molecular determinants of heart failure with normal left ventricular ejection fraction A Borbély, Z Papp, I Édes, WJ Paulus Pharmacol Rep 61 (1), 139-145, 2009 | 73 | 2009 |
| Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction N Hamdani, WJ Paulus, L Van Heerebeek, A Borbély, NM Boontje, ... European heart journal 30 (15), 1863-1872, 2009 | 69 | 2009 |
| Oxidation of myofilament protein sulfhydryl groups reduces the contractile force and its Ca2+ sensitivity in human cardiomyocytes Z Hertelendi, A Toth, A Borbély, Z Galajda, J van der Velden, GJM Stienen, ... Antioxidants & redox signaling 10 (7), 1175-1184, 2008 | 66 | 2008 |
| Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone S Szilágyi, P Pollesello, J Levijoki, H Haikala, I Bak, Á Tósaki, A Borbély, ... Journal of cardiovascular pharmacology 46 (3), 369-376, 2005 | 60 | 2005 |
| Transcriptional and posttranslational modifications of titin implications for diastole A Borbély, L van Heerebeek, WJ Paulus Circulation research 104 (1), 12-14, 2009 | 51 | 2009 |
| Rate of tension redevelopment is not modulated by sarcomere length in permeabilized human, murine, and porcine cardiomyocytes IF Édes, D Czuriga, G Csányi, S Chłopicki, FA Recchia, A Borbély, ... American Journal of Physiology-Regulatory, Integrative and Comparative …, 2007 | 49 | 2007 |
| More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease N Hamdani, A Borbély, SPGR Veenstra, V Kooij, W Vrydag, R Zaremba, ... Journal of muscle research and cell motility 31 (4), 289-301, 2010 | 48 | 2010 |
| Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy G Pölzl, J Altenberger, L Baholli, P Beltrán, A Borbély, J Comin-Colet, ... International journal of cardiology 243, 389-395, 2017 | 31 | 2017 |
| Repetitive levosimendan treatment in the management of advanced heart failure F Oliva, J Comin-Colet, F Fedele, F Fruhwald, F Gustafsson, M Kivikko, ... European Heart Journal Supplements 20 (suppl_I), I11-I20, 2018 | 29 | 2018 |
| Positive Inotropic Effect of Levosimendan is Correlated to its Stereoselective Ca2+‐Sensitizing Effect but not to Stereoselective Phosphodiesterase Inhibition P Kaheinen, P Pollesello, Z Hertelendi, A Borbély, S Szilágyi, E Nissinen, ... Basic & clinical pharmacology & toxicology 98 (1), 74-78, 2006 | 29 | 2006 |
